Doxycycline Versus Azithromycin for the Treatment of Rectal Chlamydia in Men Who Have Sex With Men: A Randomized Controlled Trial
- PMID: 33606009
- PMCID: PMC8571563
- DOI: 10.1093/cid/ciab153
Doxycycline Versus Azithromycin for the Treatment of Rectal Chlamydia in Men Who Have Sex With Men: A Randomized Controlled Trial
Abstract
Background: Azithromycin and doxycycline are both recommended treatments for rectal Chlamydia trachomatis (CT) infection, but observational studies suggest that doxycycline may be more effective.
Methods: This randomized, double-blind, placebo-controlled trial compared azithromycin (single 1-g dose) versus doxycycline (100 mg twice daily for 7 days) for the treatment of rectal CT in men who have sex with men (MSM) in Seattle and Boston. Participants were enrolled after a diagnosis of rectal CT in clinical care and underwent repeated collection of rectal swabs for nucleic acid amplification testing (NAAT) at study enrollment and 2 weeks and 4 weeks postenrollment. The primary outcome was microbiologic cure (CT-negative NAAT) at 4 weeks. The complete case (CC) population included participants with a CT-positive NAAT at enrollment and a follow-up NAAT result; the intention-to-treat (ITT) population included all randomized participants.
Results: Among 177 participants enrolled, 135 (76%) met CC population criteria for the 4-week follow-up visit. Thirty-three participants (19%) were excluded because the CT NAAT repeated at enrollment was negative. Microbiologic cure was higher with doxycycline than azithromycin in both the CC population (100% [70 of 70] vs 74% [48 of 65]; absolute difference, 26%; 95% confidence interval [CI], 16-36%; P < .001) and the ITT population (91% [80 of 88] vs 71% [63 of 89]; absolute difference, 20%; 95% CI, 9-31%; P < .001).
Conclusions: A 1-week course of doxycycline was significantly more effective than a single dose of azithromycin for the treatment of rectal CT in MSM.
Clinical trials registration: NCT03608774.
Keywords: Chlamydia trachomatis; rectal infection; sexual and gender minorities; sexually transmitted diseases; therapeutics.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures
Similar articles
-
Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis.N Engl J Med. 2021 Jun 24;384(25):2418-2427. doi: 10.1056/NEJMoa2031631. N Engl J Med. 2021. PMID: 34161706 Clinical Trial.
-
Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol.BMC Infect Dis. 2017 Jan 6;17(1):35. doi: 10.1186/s12879-016-2125-7. BMC Infect Dis. 2017. PMID: 28061753 Free PMC article.
-
Randomized, open-label, multicenter study of azithromycin compared with doxycycline for treating anorectal Chlamydia trachomatis infection concomitant to a vaginal infection (CHLAZIDOXY study).Medicine (Baltimore). 2019 Feb;98(7):e14572. doi: 10.1097/MD.0000000000014572. Medicine (Baltimore). 2019. PMID: 30762806 Free PMC article. Clinical Trial.
-
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women.Cochrane Database Syst Rev. 2019 Jan 25;1(1):CD010871. doi: 10.1002/14651858.CD010871.pub2. Cochrane Database Syst Rev. 2019. PMID: 30682211 Free PMC article.
-
Efficacy of doxycycline versus azithromycin for the treatment of rectal chlamydia: a systematic review and meta-analysis.J Antimicrob Chemother. 2021 Nov 12;76(12):3103-3110. doi: 10.1093/jac/dkab335. J Antimicrob Chemother. 2021. PMID: 34529798
Cited by
-
Phenotypic and Genotypic Antimicrobial Susceptibility Testing of Chlamydia trachomatis Isolates from Patients with Persistent or Clinical Treatment Failure in Spain.Antibiotics (Basel). 2023 May 28;12(6):975. doi: 10.3390/antibiotics12060975. Antibiotics (Basel). 2023. PMID: 37370294 Free PMC article.
-
Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches.Emerg Infect Dis. 2022 Aug;28(8):e220094. doi: 10.3201/eid2808.220094. Emerg Infect Dis. 2022. PMID: 35876565 Free PMC article.
-
Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1. MMWR Recomm Rep. 2021. PMID: 34292926 Free PMC article.
-
Treatment of Chlamydia and Gonorrhea in Primary Care and Its Patient-Level Variation: An American Family Cohort Study.Ann Fam Med. 2025 Mar 24;23(2):136-144. doi: 10.1370/afm.240164. Ann Fam Med. 2025. PMID: 40127987 Free PMC article.
-
Clinical Updates in Sexually Transmitted Infections, 2024.J Womens Health (Larchmt). 2024 Jun;33(6):827-837. doi: 10.1089/jwh.2024.0367. Epub 2024 May 21. J Womens Health (Larchmt). 2024. PMID: 38770770 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2018. 2019. Available at: https://www.cdc.gov/std/stats18/default.htm. Accessed 21 September 2020.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous